The initial pathological diagnosis inclined toward myxoid fibrosarcoma; however, molecular pathology testing (Table 2) confirmed the presence of FUS-DDIT3 fusion gene, confirming the final diagnosis of myxoid liposarcoma. Here, DDIT3 is linked to myxoid liposarcoma.